Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2012 by BioMimetic Therapeutics.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
BioMimetic Therapeutics
ClinicalTrials.gov Identifier:
NCT01746420
First received: December 7, 2012
Last updated: December 10, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)